Tata Elxsi and Dräger collaborate to drive critical care innovation in India
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
The facility will manufacture tablets, capsules, and injections for the oncology segment
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
Hepatitis B infects over 40 million people in India
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
To accelerate the development of next-generation radioconjugates to treat cancer
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Subscribe To Our Newsletter & Stay Updated